Insiders Updates
Atossa Therapeutics Inc’s latest rating changes from various analysts
Atossa Therapeutics Inc’s recent filing unveils that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0
Menu
Atossa Therapeutics Inc’s recent filing unveils that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Atossa Therapeutics Inc’s filing revealed that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Atossa Therapeutics Inc revealed its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Atossa Therapeutics Inc’s recent filing unveils that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Atossa Therapeutics Inc. (NASDAQ:ATOS) does about 563.52K shares in volume on a normal day but saw 206077 shares change hands